| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.009 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |